EUVIMEDEUVIMED entdecken
Crossref

Angiotensin Inhibition and Gastrointestinal Bleeding Prevention in Patients with Left Ventricular Assist Devices

Phillip Weeks

The VAD Journal · 2020

DOI: 10.11589/vad/e2020623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The VAD Journal, 2020. Verfasst von Phillip Weeks.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal bleeding remains a common complication in advanced heart failure patients following implantation of continuous-flow left ventricular assist devices. While the cause is likely multifactorial, development of arterial venous malformations in the gastrointestinal mucosa are a key factor. Inhibition of angiotensin II activity has been postulated to disrupt the signaling that promotes angiogenesis in these patients. We aim to review the theoretical basis for angiotensin receptor blockade, which has been proposed and explore the published evidence regarding this therapy and gastrointestinal bleeding in LVAD patients.

Zitieren

APA

Weeks, P. (2020). Angiotensin Inhibition and Gastrointestinal Bleeding Prevention in Patients with Left Ventricular Assist Devices. The VAD Journal. https://doi.org/10.11589/vad/e2020623

Vancouver

Weeks P. Angiotensin Inhibition and Gastrointestinal Bleeding Prevention in Patients with Left Ventricular Assist Devices. The VAD Journal. 2020. doi:10.11589/vad/e2020623

BibTeX
@article{Weeks2020,
  author = {Weeks, Phillip},
  title = {Angiotensin Inhibition and Gastrointestinal Bleeding Prevention in Patients with Left Ventricular Assist Devices},
  journal = {The VAD Journal},
  year = {2020},
  doi = {10.11589/vad/e2020623}
}
Kostenlos starten →